![James Woodruff Emlen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
James Woodruff Emlen
Director Técnico/Científico/I+D en MenoGenix, Inc. .
Cargos activos de James Woodruff Emlen
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
MenoGenix, Inc.
![]() MenoGenix, Inc. BiotechnologyHealth Technology MenoGenix, Inc. operates as a biotechnology company. It focuses on development of drugs for menopause and the menopause diseases. The company was founded by Debra M. Duke and Jonathan Kaufman in 2010 and is headquartered in Aurora, CO. | Director/Miembro de la Junta | - | - |
Director Técnico/Científico/I+D | - | - |
Historial de carrera de James Woodruff Emlen
Antiguos cargos conocidos de James Woodruff Emlen.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Taligen Therapeutics, Inc.
![]() Taligen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Taligen Therapeutics is a biotechnology company pioneering a new approach to treating inflammatory and immune diseases by regulating the complement system, a potent and ubiquitous immune pathway. Based on new insights and unique proprietary technology related to complement biology, Taligen is building a deep product candidate pipeline of novel protein therapeutics which selectively identify, target and concentrate on inflammatory tissues. Taligen's targeted drugs have been shown to naturally and broadly control aberrant inflammation in a broad array of genetic, orphan and large market diseases. Founded in 2004, Taligen Therapeutics maintains its headquarters in Cambridge, Massachusetts. | Fundador | 07/08/2009 | 24/02/2012 |
Presidente | 01/03/2004 | 16/04/2010 | |
University of Washington
![]() University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | - | - |
INTERMUNE INC | Director Técnico/Científico/I+D | - | - |
Connetics Corp.
![]() Connetics Corp. BiotechnologyHealth Technology Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | - | - |
The University of Colorado | Corporate Officer/Principal | - | - |
Formación de James Woodruff Emlen.
Stanford University | Undergraduate Degree |
University of California San Diego | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 9 |
Operativa
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Founder | 1 |
Sectorial
Health Technology | 5 |
Consumer Services | 5 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 4 |
---|---|
Connetics Corp.
![]() Connetics Corp. BiotechnologyHealth Technology Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA. | Health Technology |
InterMune, Inc.
![]() InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Taligen Therapeutics, Inc.
![]() Taligen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Taligen Therapeutics is a biotechnology company pioneering a new approach to treating inflammatory and immune diseases by regulating the complement system, a potent and ubiquitous immune pathway. Based on new insights and unique proprietary technology related to complement biology, Taligen is building a deep product candidate pipeline of novel protein therapeutics which selectively identify, target and concentrate on inflammatory tissues. Taligen's targeted drugs have been shown to naturally and broadly control aberrant inflammation in a broad array of genetic, orphan and large market diseases. Founded in 2004, Taligen Therapeutics maintains its headquarters in Cambridge, Massachusetts. | Health Technology |
MenoGenix, Inc.
![]() MenoGenix, Inc. BiotechnologyHealth Technology MenoGenix, Inc. operates as a biotechnology company. It focuses on development of drugs for menopause and the menopause diseases. The company was founded by Debra M. Duke and Jonathan Kaufman in 2010 and is headquartered in Aurora, CO. | Health Technology |
- Bolsa de valores
- Insiders
- James Woodruff Emlen
- Experiencia